Amneal Pharmaceuticals, Inc.
AMRXNASDAQHealthcare● Active
$13.79
+$0.04(+0.25%)
Market Cap$4.4B
P/E Ratio—
52W High$15.42
52W Low$7.07
Amneal Pharmaceuticals, Inc.（AMRX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · AMRX · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $3.02B | $2.79B | $2.39B | $2.21B | $2.09B |
| Cost of Revenue | $1.88B | $1.77B | $1.53B | $1.42B | $1.32B |
| Gross Profit | $1.14B | $1.02B | $0.86B | $0.79B | $0.77B |
| Gross Margin %(computed) | 37.63% | 36.52% | 36.09% | 35.78% | 36.73% |
| Operating Expenses | |||||
| R&D Expenses | $0.19B | $0.19B | $0.19B | $0.21B | $0.21B |
| G&A Expenses | $0.00B | $0.44B | $0.42B | $0.38B | $0.00B |
| Total Operating Expenses | $0.71B | $0.77B | $0.66B | $0.89B | $0.62B |
| Operating Income | $0.42B | $0.25B | $0.20B | ($0.09B) | $0.15B |
| Operating Margin %(computed) | 14.02% | 8.92% | 8.54% | -4.29% | 7.29% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.16B | $0.00B |
| Interest Expense | $0.24B | $0.26B | $0.21B | $0.16B | $0.14B |
| Income Before Tax | $0.14B | ($0.06B) | ($0.04B) | ($0.25B) | $0.03B |
| Income Tax Expense | $0.01B | $0.02B | $0.01B | $0.01B | $0.01B |
| Net Income | $0.07B | ($0.12B) | ($0.08B) | ($0.13B) | $0.01B |
| Net Margin %(computed) | 2.39% | -4.18% | -3.51% | -5.88% | 0.51% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.23 | $-0.38 | $-0.48 | $-0.86 | $0.07 |
| Wtd Avg Shares | 0.31B | 0.31B | 0.17B | 0.15B | 0.15B |
| EBITDA | $0.60B | $0.44B | $0.50B | $0.44B | $0.40B |
| EBITDA Margin %(computed) | 20.00% | 15.74% | 20.92% | 19.90% | 19.16% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Amneal Pharmaceuticals, Inc.
关于Amneal Pharmaceuticals, Inc.（AMRX）损益表
Amneal Pharmaceuticals, Inc.（AMRX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，AMRX实现营收$3.02B，毛利润$1.14B（毛利率37.63%），净利润$0.07B（净利率2.39%）。
常见问题
AMRX · 4 问Amneal Pharmaceuticals, Inc.（AMRX）2025财年营收为$3.02B，同比up8.0%。
AMRX revenueAMRX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08